Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A Study to Assess the Pharmacokinetics (absorption, distribution, metabolisation, excretion), Pharmacodynamics (biochemical and physiological effects of the drug), Efficacy, Safety, Tolerability, and Immunogenicity (Immune response) of a Single, Subcutaneous Dose of 100μg/kg XM22 in 21 Children with Ewing Family of Tumors or Rhabdomyosarcoma https://www.kusajili.com:443/Trial/hpjaX3gnm0mx4tncOg9Ovg%24a-study-to-assess-the-pharmacokinetics-absorption-distribution-metabolisation-excretion-pharmacodynamics-biochemical-and-physio
I have read and accept the terms of use of the site and the Privacy Policy
Send your message